Anti-atherogenic mechanisms of high density lipoprotein: Effects on myeloid cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 3, 2012, Pages 513-521

  Murphy, Andrew J ^a   Westerterp, Marit ^a   Yvan Charvet, Laurent ^a   Tall, Alan R ^a  

^a Columbia University ^*  (United States)

Author keywords

Atherosclerosis; Hematopoietic stem and multipotent progenitor cell; High density lipoprotein; Macrophage; Monocyte; Neutrophil

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; JANUS KINASE 2; STAT3 PROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW CELL; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL TRANSPORT; DENDRITIC CELL; FOAM CELL; HEMATOPOIETIC STEM CELL; KNOCKOUT MOUSE; MACROPHAGE; MONOCYTE; MONOCYTOSIS; MOUSE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; REMISSION; REVIEW; TRANSGENIC MOUSE;

ANIMALS; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHOLESTEROL; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LIPOPROTEINS, HDL; LYMPHOCYTES; MYELOID CELLS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84857633380     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2011.08.003     Document Type: Review

References (106)

1. K.J. Williams, and I. Tabas The response-to-retention hypothesis of early atherogenesis Arterioscler. Thromb. Vasc. Biol. 15 1995 551 561
2. K.J. Williams, and I. Tabas The response-to-retention hypothesis of atherogenesis reinforced Curr. Opin. Lipidol. 9 1998 471 474 (Pubitemid 28495557)
3. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
4. T.A. Seimon, M.J. Nadolski, X. Liao, J. Magallon, M. Nguyen, N.T. Feric, M.L. Koschinsky, R. Harkewicz, J.L. Witztum, S. Tsimikas, D. Golenbock, K.J. Moore, and I. Tabas Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress Cell Metab. 12 2010 467 482
5. C.R. Stewart, L.M. Stuart, K. Wilkinson, J.M. van Gils, J. Deng, A. Halle, K.J. Rayner, L. Boyer, R. Zhong, W.A. Frazier, A. Lacy-Hulbert, J. El Khoury, D.T. Golenbock, and K.J. Moore CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer Nat. Immunol. 11 2010 155 161
6. N. Terasaka, N. Wang, L. Yvan-Charvet, and A.R. Tall High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1 Proc. Natl. Acad. Sci. U.S.A. 104 2007 15093 15098 (Pubitemid 47619598)
7. L. Yvan-Charvet, T.A. Pagler, T.A. Seimon, E. Thorp, C.L. Welch, J.L. Witztum, I. Tabas, and A.R. Tall ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis Circ. Res. 106 2010 1861 1869
8. L. Yvan-Charvet, M. Ranalletta, N. Wang, S. Han, N. Terasaka, R. Li, C. Welch, and A.R. Tall Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice J. Clin. Invest. 117 2007 3900 3908 (Pubitemid 350224099)
9. A.J. Murphy, J.P. Chin-Dusting, D. Sviridov, and K.J. Woollard The anti inflammatory effects of high density lipoproteins Curr. Med. Chem. 16 2009 667 675
10. A.J. Murphy, and K.J. Woollard High-density lipoprotein: a potent inhibitor of inflammation Clin. Exp. Pharmacol. Physiol. 37 2010 710 718
11. L. Yvan-Charvet, T. Pagler, E.L. Gautier, S. Avagyan, R.L. Siry, S. Han, C.L. Welch, N. Wang, G.J. Randolph, H.W. Snoeck, and A.R. Tall ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation Science 328 2010 1689 1693
12. G.A. Francis, R.H. Knopp, and J.F. Oram Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease J. Clin. Invest. 96 1995 78 87
13. J.F. Oram, A.J. Mendez, J. Lymp, T.J. Kavanagh, and C.L. Halbert Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells J. Lipid Res. 40 1999 1769 1781 (Pubitemid 29477247)
14. M. Bodzioch, E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, W.E. Kaminski, H.W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K.J. Lackner, and G. Schmitz The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease Nat. Genet. 22 1999 347 351 (Pubitemid 29369524)
15. A. Brooks-Wilson, M. Marcil, S.M. Clee, L.H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J.A. Collins, H.O. Molhuizen, O. Loubser, B.F. Ouelette, K. Fichter, K.J. Ashbourne-Excoffon, C.W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J.J. Kastelein, J. Genest Jr., and M.R. Hayden Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency Nat. Genet. 22 1999 336 345 (Pubitemid 29369523)
16. R.M. Lawn, D.P. Wade, M.R. Garvin, X. Wang, K. Schwartz, J.G. Porter, J.J. Seilhamer, A.M. Vaughan, and J.F. Oram The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway J. Clin. Invest. 104 1999 R25 R31
17. A.T. Remaley, S. Rust, M. Rosier, C. Knapper, L. Naudin, C. Broccardo, K.M. Peterson, C. Koch, I. Arnould, C. Prades, N. Duverger, H. Funke, G. Assman, M. Dinger, M. Dean, G. Chimini, S. Santamarina-Fojo, D.S. Fredrickson, P. Denefle, and H.B. Brewer Jr. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred Proc. Natl. Acad. Sci. U.S.A. 96 1999 12685 12690 (Pubitemid 29513563)
18. S. Rust, M. Rosier, H. Funke, J. Real, Z. Amoura, J.C. Piette, J.F. Deleuze, H.B. Brewer, N. Duverger, P. Denefle, and G. Assmann Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 Nat. Genet. 22 1999 352 355 (Pubitemid 29369525)
19. M.A. Kennedy, G.C. Barrera, K. Nakamura, A. Baldan, P. Tarr, M.C. Fishbein, J. Frank, O.L. Francone, and P.A. Edwards ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation Cell Metab. 1 2005 121 131 (Pubitemid 43977167)
20. N. Wang, D. Lan, W. Chen, F. Matsuura, and A.R. Tall ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins Proc. Natl. Acad. Sci. U.S.A. 101 2004 9774 9779 (Pubitemid 38869312)
21. S.H. Najafi-Shoushtari, F. Kristo, Y. Li, T. Shioda, D.E. Cohen, R.E. Gerszten, and A.M. Naar MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis Science 328 2010 1566 1569
22. K.J. Rayner, Y. Suarez, A. Davalos, S. Parathath, M.L. Fitzgerald, N. Tamehiro, E.A. Fisher, K.J. Moore, and C. Fernandez-Hernando MiR-33 contributes to the regulation of cholesterol homeostasis Science 328 2010 1570 1573
23. V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D.S. Weiss, Y. Weinrauch, and A. Zychlinsky Neutrophil extracellular traps kill bacteria Science 303 2004 1532 1535 (Pubitemid 38314426)
24. T. Horie, K. Ono, M. Horiguchi, H. Nishi, T. Nakamura, K. Nagao, M. Kinoshita, Y. Kuwabara, H. Marusawa, Y. Iwanaga, K. Hasegawa, M. Yokode, T. Kimura, and T. Kita MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo Proc. Natl. Acad. Sci. U.S.A. 107 2010 17321 17326
25. T.J. Marquart, R.M. Allen, D.S. Ory, and A. Baldan miR-33 links SREBP-2 induction to repression of sterol transporters Proc. Natl. Acad. Sci. U.S.A. 107 2010 12228 12232
26. E.P. de Grouw, M.H. Raaijmakers, J.B. Boezeman, B.A. van der Reijden, L.T. van de Locht, T.J. de Witte, J.H. Jansen, and R.A. Raymakers Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34 + CD38- cells Leukemia 20 2006 750 754
27. E.C. Forsberg, S.S. Prohaska, S. Katzman, G.C. Heffner, J.M. Stuart, and I.L. Weissman Differential expression of novel potential regulators in hematopoietic stem cells PLoS Genet. 1 2005 e28
28. S.D. Peeters, D.M. van der Kolk, G. de Haan, L. Bystrykh, F. Kuipers, E.G. de Vries, and E. Vellenga Selective expression of cholesterol metabolism genes in normal CD34 + CD38- cells with a heterogeneous expression pattern in AML cells Exp. Hematol. 34 2006 622 630
29. L. Tang, S.M. Bergevoet, C. Gilissen, T. de Witte, J.H. Jansen, B.A. van der Reijden, and R.A. Raymakers Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells BMC Pharmacol. 10 2010 12
30. A.L. Gomes, T. Carvalho, J. Serpa, C. Torre, and S. Dias Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis Blood 115 2010 3886 3894
31. M. Drechsler, R.T. Megens, M. van Zandvoort, C. Weber, and O. Soehnlein Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis Circulation 122 2010 1837 1845
32. F.K. Swirski, P. Libby, E. Aikawa, P. Alcaide, F.W. Luscinskas, R. Weissleder, and M.J. Pittet Ly-6Chi monocytes dominate hypercholesterolemia- associated monocytosis and give rise to macrophages in atheromata J. Clin. Invest. 117 2007 195 205 (Pubitemid 46048466)
33. F. Tacke, D. Alvarez, T.J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, N. van Rooijen, S.A. Lira, A.J. Habenicht, and G.J. Randolph Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques J. Clin. Invest. 117 2007 185 194 (Pubitemid 46048465)
34. K.J. Woollard, and F. Geissmann Monocytes in atherosclerosis: subsets and functions Nat. Rev. Cardiol. 7 2010 77 86
35. A.J. Murphy, T. Pagler, M. Akhtari, and A.R. Tall Abstract 19263: enhancing cholesterol efflux pathways suppresses hematopoietic stem cell proliferation and monocytosis in apoE-/- mice Circulation 122 2010 A19263
36. J.H. Qiao, J. Tripathi, N.K. Mishra, Y. Cai, S. Tripathi, X.P. Wang, S. Imes, M.C. Fishbein, S.K. Clinton, P. Libby, A.J. Lusis, and T.B. Rajavashisth Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice Am. J. Pathol. 150 1997 1687 1699 (Pubitemid 27193816)
37. T. Rajavashisth, J.H. Qiao, S. Tripathi, J. Tripathi, N. Mishra, M. Hua, X.P. Wang, A. Loussararian, S. Clinton, P. Libby, and A. Lusis Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice J. Clin. Invest. 101 1998 2702 2710 (Pubitemid 28294579)
38. A.J. Armstrong, A.K. Gebre, J.S. Parks, and C.C. Hedrick ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation J. Immunol. 184 2010 173 183
39. S.J. Bensinger, M.N. Bradley, S.B. Joseph, N. Zelcer, E.M. Janssen, M.A. Hausner, R. Shih, J.S. Parks, P.A. Edwards, B.D. Jamieson, and P. Tontonoz LXR signaling couples sterol metabolism to proliferation in the acquired immune response Cell 134 2008 97 111 (Pubitemid 351905740)
40. A.J. Wilhelm, M. Zabalawi, J.M. Grayson, A.E. Weant, A.S. Major, J. Owen, M. Bharadwaj, R. Walzem, L. Chan, K. Oka, M.J. Thomas, and M.G. Sorci-Thomas Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity Arterioscler. Thromb. Vasc. Biol. 29 2009 843 849
41. - mice J. Biol. Chem. 285 2010 36158 36169
42. B.G. Drew, N.H. Fidge, G. Gallon-Beaumier, B.E. Kemp, and B.A. Kingwell High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation Proc. Natl. Acad. Sci. U.S.A. 101 2004 6999 7004 (Pubitemid 38596432)
43. M. Gong, M. Wilson, T. Kelly, W. Su, J. Dressman, J. Kincer, S.V. Matveev, L. Guo, T. Guerin, X.A. Li, W. Zhu, A. Uittenbogaard, and E.J. Smart HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner J. Clin. Invest. 111 2003 1579 1587 (Pubitemid 38063291)
44. I.S. Yuhanna, Y. Zhu, B.E. Cox, L.D. Hahner, S. Osborne-Lawrence, P. Lu, Y.L. Marcel, R.G. Anderson, M.E. Mendelsohn, H.H. Hobbs, and P.W. Shaul High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase Nat. Med. 7 2001 853 857 (Pubitemid 32691642)
45. G.W. Cockerill, K.A. Rye, J.R. Gamble, M.A. Vadas, and P.J. Barter High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules Arterioscler. Thromb. Vasc. Biol. 15 1995 1987 1994
46. K.C. McGrath, X.H. Li, R. Puranik, E.C. Liong, J.T. Tan, V.M. Dy, B.A. DiBartolo, P.J. Barter, K.A. Rye, and A.K. Heather Role of 3beta-hydroxysteroid- delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells Arterioscler. Thromb. Vasc. Biol. 29 2009 877 882
47. S.J. Nicholls, G.J. Dusting, B. Cutri, S. Bao, G.R. Drummond, K.A. Rye, and P.J. Barter Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits Circulation 111 2005 1543 1550 (Pubitemid 40470651)
48. R. Puranik, S. Bao, E. Nobecourt, S.J. Nicholls, G.J. Dusting, P.J. Barter, D.S. Celermajer, and K.A. Rye Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo Atherosclerosis 196 2008 240 247
49. A.J. Murphy, K.J. Woollard, A. Hoang, N. Mukhamedova, R.A. Stirzaker, S.P. McCormick, A.T. Remaley, D. Sviridov, and J. Chin-Dusting High-density lipoprotein reduces the human monocyte inflammatory response Arterioscler. Thromb. Vasc. Biol. 28 2008 2071 2077
50. S. Patel, B.G. Drew, S. Nakhla, S.J. Duffy, A.J. Murphy, P.J. Barter, K.A. Rye, J. Chin-Dusting, A. Hoang, D. Sviridov, D.S. Celermajer, and B.A. Kingwell Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes J. Am. Coll. Cardiol. 53 2009 962 971
51. J.A. Shaw, A. Bobik, A. Murphy, P. Kanellakis, P. Blombery, N. Mukhamedova, K. Woollard, S. Lyon, D. Sviridov, and A.M. Dart Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque Circ. Res. 103 2008 1084 1091
52. W. Diederich, E. Orso, W. Drobnik, and G. Schmitz Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42 Atherosclerosis 159 2001 313 324 (Pubitemid 33127245)
53. C.A. Bursill, M.L. Castro, D.T. Beattie, S. Nakhla, E. van der Vorst, A.K. Heather, P.J. Barter, and K.A. Rye High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo Arterioscler. Thromb. Vasc. Biol. 30 2010 1773 1778
54. O. Soehnlein An elegant defense: how neutrophils shape the immune response Trends Immunol. 30 2009 511 512
55. P.M. Sweetnam, H.F. Thomas, W. Yarnell, I.A. Baker, and P.C. Elwood Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies Am. J. Epidemiol. 145 1997 416 421 (Pubitemid 27084213)
56. - mice Am. J. Pathol. 177 2010 493 500
57. F.B. Araujo, D.S. Barbosa, C.Y. Hsin, R.C. Maranhao, and D.S. Abdalla Evaluation of oxidative stress in patients with hyperlipidemia Atherosclerosis 117 1995 61 71
58. R. Mazor, R. Shurtz-Swirski, R. Farah, B. Kristal, G. Shapiro, F. Dorlechter, M. Cohen-Mazor, E. Meilin, S. Tamara, and S. Sela Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients Atherosclerosis 197 2008 937 943 (Pubitemid 351417898)
59. O. Soehnlein, L. Lindbom, and C. Weber Mechanisms underlying neutrophil-mediated monocyte recruitment Blood 114 2009 4613 4623
60. H. Oh, E.R. Mohler 3rd, A. Tian, T. Baumgart, and S.L. Diamond Membrane cholesterol is a biomechanical regulator of neutrophil adhesion Arterioscler. Thromb. Vasc. Biol. 29 2009 1290 1297
61. A. Zernecke, I. Bot, Y. Djalali-Talab, E. Shagdarsuren, K. Bidzhekov, S. Meiler, R. Krohn, A. Schober, M. Sperandio, O. Soehnlein, J. Bornemann, F. Tacke, E.A. Biessen, and C. Weber Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis Circ. Res. 102 2008 209 217 (Pubitemid 351651125)
62. A.J. Murphy, K.J. Woollard, A. Suhartoyo, R.A. Stirzaker, J. Shaw, D. Sviridov, and J.P. Chin-Dusting Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein a-I in in vitro and in vivo models of inflammation Arterioscler. Thromb. Vasc. Biol. 31 2011 1333 1341
63. S. Itoh, C. Susuki, K. Takeshita, K. Nagata, and T. Tsuji Redistribution of P-selectin glycoprotein ligand-1 (PSGL-1) in chemokine-treated neutrophils: a role of lipid microdomains J. Leukoc. Biol. 81 2007 1414 1421 (Pubitemid 46827964)
64. K.B. Kannan, D. Barlos, and C.J. Hauser Free cholesterol alters lipid raft structure and function regulating neutrophil Ca2+ entry and respiratory burst: correlations with calcium channel raft trafficking J. Immunol. 178 2007 5253 5261 (Pubitemid 46595310)
65. L.M. Pierini, R.J. Eddy, M. Fuortes, S. Seveau, C. Casulo, and F.R. Maxfield Membrane lipid organization is critical for human neutrophil polarization J. Biol. Chem. 278 2003 10831 10841 (Pubitemid 36800357)
66. D. Shao, A.W. Segal, and L.V. Dekker Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils FEBS Lett. 550 2003 101 106 (Pubitemid 37281365)
67. E.Y. Chiang, A. Hidalgo, J. Chang, and P.S. Frenette Imaging receptor microdomains on leukocyte subsets in live mice Nat. Methods 4 2007 219 222 (Pubitemid 46358870)
68. K.J. Woollard, A. Suhartoyo, E.E. Harris, S.U. Eisenhardt, S.P. Jackson, K. Peter, A.M. Dart, M.J. Hickey, and J.P. Chin-Dusting Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation Circ. Res. 103 2008 1128 1138
69. H.M. Dansky, S.A. Charlton, C.B. Barlow, M. Tamminen, J.D. Smith, J.S. Frank, and J.L. Breslow Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium J. Clin. Invest. 104 1999 31 39 (Pubitemid 29534342)
70. R. Out, W. Jessup, W. Le Goff, M. Hoekstra, I.C. Gelissen, Y. Zhao, L. Kritharides, G. Chimini, J. Kuiper, M.J. Chapman, T. Huby, T.J. Van Berkel, and M. Van Eck Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1 Circ. Res. 102 2008 113 120
71. A.R. Tall, L. Yvan-Charvet, N. Terasaka, T. Pagler, and N. Wang HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis Cell Metab. 7 2008 365 375 (Pubitemid 351598023)
72. L. Yvan-Charvet, N. Wang, and A.R. Tall Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses Arterioscler. Thromb. Vasc. Biol. 30 2010 139 143
73. X. Zhu, J.S. Owen, M.D. Wilson, H. Li, G.L. Griffiths, M.J. Thomas, E.M. Hiltbold, M.B. Fessler, and J.S. Parks Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol J. Lipid Res. 51 2010 3196 3206
74. S. Akashi, R. Shimazu, H. Ogata, Y. Nagai, K. Takeda, M. Kimoto, and K. Miyake Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages J. Immunol. 164 2000 3471 3475 (Pubitemid 30169795)
75. M. Triantafilou, K. Miyake, D.T. Golenbock, and K. Triantafilou Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation J. Cell Sci. 115 2002 2603 2611 (Pubitemid 34778077)
76. L. Yvan-Charvet, C. Welch, T.A. Pagler, M. Ranalletta, M. Lamkanfi, S. Han, M. Ishibashi, R. Li, N. Wang, and A.R. Tall Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions Circulation 118 2008 1837 1847
77. L.E. Smythies, C.R. White, A. Maheshwari, M.N. Palgunachari, G.M. Anantharamaiah, M. Chaddha, A.R. Kurundkar, and G. Datta Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages Am. J. Physiol. Cell Physiol. 298 2010 C1538 C1548
78. M. Suzuki, D.K. Pritchard, L. Becker, A.N. Hoofnagle, N. Tanimura, T.K. Bammler, R.P. Beyer, R. Bumgarner, T. Vaisar, M.C. de Beer, F.C. de Beer, K. Miyake, J.F. Oram, and J.W. Heinecke High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide Circulation 122 2010 1919 1927
79. C.T. Park, and S.D. Wright Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins J. Biol. Chem. 271 1996 18054 18060 (Pubitemid 26250791)
80. M.M. Wurfel, E. Hailman, and S.D. Wright Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein J. Exp. Med. 181 1995 1743 1754
81. R.L. Kitchens, G. Wolfbauer, J.J. Albers, and R.S. Munford Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface J. Biol. Chem. 274 1999 34116 34122 (Pubitemid 129511747)
82. Z. Jiang, P. Georgel, X. Du, L. Shamel, S. Sovath, S. Mudd, M. Huber, C. Kalis, S. Keck, C. Galanos, M. Freudenberg, and B. Beutler CD14 is required for MyD88-independent LPS signaling Nat. Immunol. 6 2005 565 570 (Pubitemid 41710726)
83. R. Patino, J. Ibarra, A. Rodriguez, M.R. Yague, E. Pintor, A. Fernandez-Cruz, and A. Figueredo Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression Am. J. Cardiol. 85 2000 1288 1291 (Pubitemid 30314658)
84. D. Pajkrt, J.E. Doran, F. Koster, P.G. Lerch, B. Arnet, T. van der Poll, J.W. ten Cate, and S.J. van Deventer Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia J. Exp. Med. 184 1996 1601 1608 (Pubitemid 26404453)
85. R.S. Birjmohun, S.I. van Leuven, J.H. Levels, C. van 't Veer, J.A. Kuivenhoven, J.C. Meijers, M. Levi, J.J. Kastelein, T. van der Poll, and E.S. Stroes High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans Arterioscler. Thromb. Vasc. Biol. 27 2007 1153 1158 (Pubitemid 46641971)
86. H. Kamata, S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases Cell 120 2005 649 661 (Pubitemid 40343077)
87. C. Tang, Y. Liu, P.S. Kessler, A.M. Vaughan, and J.F. Oram The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor J. Biol. Chem. 284 2009 32336 32343
88. A.M. Vaughan, C. Tang, and J.F. Oram ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation J. Lipid Res. 50 2009 285 292
89. L.M. Williams, U. Sarma, K. Willets, T. Smallie, F. Brennan, and B.M. Foxwell Expression of constitutively active STAT3 can replicate the cytokine-suppressive activity of interleukin-10 in human primary macrophages J. Biol. Chem. 282 2007 6965 6975 (Pubitemid 47093676)
90. E.M. Benkhart, M. Siedlar, A. Wedel, T. Werner, and H.W. Ziegler-Heitbrock Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression J. Immunol. 165 2000 1612 1617 (Pubitemid 30604599)
91. A.M. O'Farrell, Y. Liu, K.W. Moore, and A.L. Mui IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways EMBO J. 17 1998 1006 1018 (Pubitemid 28077655)
92. K. Yin, X. Deng, Z.C. Mo, G.J. Zhao, J. Jiang, L.B. Cui, C.Z. Tan, G.B. Wen, Y. Fu, and C.K. Tang Tristetraprolin-dependent Post-transcriptional Regulation of Inflammatory Cytokine mRNA Expression by Apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3 J. Biol. Chem. 286 2011 13834 13845
93. J.E. Feig, J.X. Rong, R. Shamir, M. Sanson, Y. Vengrenyuk, J. Liu, K. Rayner, K. Moore, M. Garabedian, and E.A. Fisher HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells Proc. Natl. Acad. Sci. U.S.A. 108 2011 7166 7171
94. J.E. Feig, S. Parathath, J.X. Rong, S.L. Mick, Y. Vengrenyuk, L. Grauer, S.G. Young, and E.A. Fisher Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques Circulation 123 2011 989 998
95. J.E. Feig, I. Pineda-Torra, M. Sanson, M.N. Bradley, Y. Vengrenyuk, D. Bogunovic, E.L. Gautier, D. Rubinstein, C. Hong, J. Liu, C. Wu, N. van Rooijen, N. Bhardwaj, M. Garabedian, P. Tontonoz, and E.A. Fisher LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression J. Clin. Invest. 120 2010 4415 4424
96. K. Gaus, L. Kritharides, G. Schmitz, A. Boettcher, W. Drobnik, T. Langmann, C.M. Quinn, A. Death, R.T. Dean, and W. Jessup Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages FASEB J. 18 2004 574 576
97. C. Qin, T. Nagao, I. Grosheva, F.R. Maxfield, and L.M. Pierini Elevated plasma membrane cholesterol content alters macrophage signaling and function Arterioscler. Thromb. Vasc. Biol. 26 2006 372 378 (Pubitemid 43732202)
98. T. Nagao, C. Qin, I. Grosheva, F.R. Maxfield, and L.M. Pierini Elevated cholesterol levels in the plasma membranes of macrophages inhibit migration by disrupting RhoA regulation Arterioscler. Thromb. Vasc. Biol. 27 2007 1596 1602 (Pubitemid 46986115)
99. T.A. Pagler, M. Wang, M. Mondal, A.J. Murphy, M. Westerterp, K.J. Moore, F.R. Maxfield, and A.R. Tall Deletion of ABCA1 and ABCG1 impairs macrophage migration because of increased Rac1 signaling Circ. Res. 108 2011 194 200
100. S. Potteaux, E.L. Gautier, S.B. Hutchison, N. van Rooijen, D.J. Rader, M.J. Thomas, M.G. Sorci-Thomas, and G.J. Randolph Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression J. Clin. Invest. 121 2011 2025 2036
101. E.M. deGoma, R.L. deGoma, and D.J. Rader Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches J. Am. Coll. Cardiol. 51 2008 2199 2211 (Pubitemid 351754991)
102. A.J. Murphy, A.T. Remaley, and D. Sviridov HDL therapy: two kinds of right? Curr. Pharm. Des. 16 2010 4134 4147
103. G.H. Rothblat, and M.C. Phillips High-density lipoprotein heterogeneity and function in reverse cholesterol transport Curr. Opin. Lipidol. 21 2010 229 238
104. K.A. Rye, C.A. Bursill, G. Lambert, F. Tabet, and P.J. Barter The metabolism and anti-atherogenic properties of HDL J. Lipid Res. 50 2009 S195 S200 (Suppl)
105. B.G. Drew, S.J. Duffy, M.F. Formosa, A.K. Natoli, D.C. Henstridge, S.A. Penfold, W.G. Thomas, N. Mukhamedova, B. de Courten, J.M. Forbes, F.Y. Yap, D.M. Kaye, G. van Hall, M.A. Febbraio, B.E. Kemp, D. Sviridov, G.R. Steinberg, and B.A. Kingwell High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus Circulation 119 2009 2103 2111
106. M.A. Fryirs, P.J. Barter, M. Appavoo, B.E. Tuch, F. Tabet, A.K. Heather, and K.A. Rye Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion Arterioscler. Thromb. Vasc. Biol. 30 2010 1642 1648